Table 3 Top 20 curated enriched gene sets in circulating lymphocytes and monocytes of each group comparison by GSEA (p < 0.05, FDR q-value < 0.05 and FWER p-value < 0.05).

From: Circulating lymphocytes and monocytes transcriptomic analysis of patients with type 2 diabetes mellitus, dyslipidemia and periodontitis

T2DMpoorly-DL-P vs Healthy

      
 

GS follow link to MSigDB

SIZE

ES

NES

NOM p-val

FDR q-val

FWER p-val

1

JISON_SICKLE_CELL_DISEASE_UP

177

−1

−2.36

0

0

0

2

RAGHAVACHARI_PLATELET_SPECIFIC_GENES

69

−1

−2.27

0

0

0

3

REACTOME_ANTIMICROBIAL_PEPTIDES

72

−1

−2.19

0

0

0

4

BROWNE_INTERFERON_RESPONSIVE_GENES

65

−1

−2.17

0

0

0

5

TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP

180

−1

−2.12

0

0

0

6

MOSERLE_IFNA_RESPONSE

30

−1

−2.11

0

0

0

7

WIERENGA_STAT5A_TARGETS_DN

187

−1

−2.11

0

0

0

8

HECKER_IFNB1_TARGETS

90

−1

−2.11

0

0

0

9

BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE

73

−1

−2.08

0

0

0

10

REACTOME_NEUTROPHIL_DEGRANULATION

453

−1

−2.07

0

0

0

11

TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP

190

−1

−2.05

0

0

0

12

TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP

157

−1

−2.04

0

0

0

13

REACTOME_DEFENSINS

29

−1

−2.04

0

0

0

14

BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS

27

−1

−2.03

0

0

0

15

HAHTOLA_SEZARY_SYNDROM_UP

94

−1

−2.03

0

0

0

16

SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP

72

−1

−2.02

0

0

0

17

REACTOME_INTERFERON_ALPHA_BETA_SIGNALING

63

−1

−2.02

0

0

0

18

SANA_RESPONSE_TO_IFNG_UP

70

−1

−2

0

0

0

19

TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN

121

−1

−2

0

0

0

20

DER_IFN_ALPHA_RESPONSE_UP

69

−1

−2

0

0

0

T2DMwell-DL-P vs Healthy

 

GS follow link to MSigDB

SIZE

ES

NES

NOM p-val

FDR q-val

FWER p-val

1

RAGHAVACHARI_PLATELET_SPECIFIC_GENES

69

−1

−2.333

0

0

0

2

REACTOME_ANTIMICROBIAL_PEPTIDES

72

−1

−2.16

0

0

0

3

PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN

28

−1

−2.018

0

0

0

4

REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2PLUS

128

−1

−1.986

0

0

0

5

COWLING_MYCN_TARGETS

41

−1

−1.978

0

0

0

6

JISON_SICKLE_CELL_DISEASE_UP

177

−1

−1.977

0

0

0

7

RICKMAN_HEAD_AND_NECK_CANCER_B

52

−1

−1.909

0

0.0034737

0.019

8

REACTOME_NEUTROPHIL_DEGRANULATION

453

−1

−1.892

0

0.0059291

0.037

9

MURATA_VIRULENCE_OF_H_PILORI

21

−1

−1.886

0

0.0068948

0.049

10

KAMIKUBO_MYELOID_CEBPA_NETWORK

30

−1

−1.885

0

0.0063283

0.049

DL-P vs Healthy

 

GS follow link to MSigDB

SIZE

ES

NES

NOM p-val

FDR q-val

FWER p-val

1

RAGHAVACHARI_PLATELET_SPECIFIC_GENES

69

−1

−2.394

0

0

0

2

WIERENGA_STAT5A_TARGETS_DN

187

−1

−2.276

0

0

0

3

PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN

28

−1

−2.204

0

0

0

4

REACTOME_ANTIMICROBIAL_PEPTIDES

72

−1

−2.166

0

0

0

5

VALK_AML_CLUSTER_8

25

−1

−2.143

0

0

0

6

GNATENKO_PLATELET_SIGNATURE

42

−1

−2.123

0

0

0

7

RICKMAN_HEAD_AND_NECK_CANCER_B

52

−1

−2.108

0

0

0

8

REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION

78

−1

−2.06

0

3.22E-04

0.002

9

HAHTOLA_SEZARY_SYNDROM_UP

94

−1

−2.059

0

2.86E-04

0.002

10

REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2PLUS

128

−1

−2.043

0

3.85E-04

0.003

11

TENEDINI_MEGAKARYOCYTE_MARKERS

61

−1

−2.034

0

4.68E-04

0.004

12

JAATINEN_HEMATOPOIETIC_STEM_CELL_DN

228

−1

−2.009

0

8.62E-04

0.008

13

REACTOME_NEUTROPHIL_DEGRANULATION

453

−1

−2.002

0

8.96E-04

0.009

14

REACTOME_AMYLOID_FIBER_FORMATION

89

−1

−1.989

0

0.0011131

0.011

15

TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN

121

−1

−1.988

0

0.0010389

0.011

16

SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN

144

−1

−1.985

0

9.74E-04

0.011

17

VALK_AML_CLUSTER_7

27

−1

−1.977

0

0.0011464

0.014

18

JISON_SICKLE_CELL_DISEASE_UP

177

−1

−1.962

0

0.0017301

0.022

Periodontitis vs Healthy

 

GS follow link to MSigDB

SIZE

ES

NES

NOM p-val

FDR q-val

FWER p-val

1

REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT

39

−1

−2.334

0

0

0

2

REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS

32

−1

−2.256

0

0

0

3

FARMER_BREAST_CANCER_CLUSTER_1

45

−1

−2.242

0

0

0

4

REACTOME_COMPLEMENT_CASCADE

71

−1

−2.222

0

0

0

5

REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA

30

−1

−2.221

0

0

0

6

REACTOME_FCERI_MEDIATED_CAPLUS2_MOBILIZATION

48

−1

−2.151

0

0

0

7

JISON_SICKLE_CELL_DISEASE_UP

177

−1

−2.136

0

0

0

8

RAGHAVACHARI_PLATELET_SPECIFIC_GENES

69

−1

−2.127

0

0

0

9

REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION

33

−1

−2.116

0

0

0

10

REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION

49

−1

−2.112

0

0

0

11

REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES

55

−1

−2.099

0

0

0

12

REACTOME_REGULATION_OF_ACTIN_DYNAMICS_FOR_PHAGOCYTIC_CUP_FORMATION

77

−1

−2.062

0

0

0

13

REACTOME_FCGR_ACTIVATION

30

−1

−2.058

0

0

0

14

REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3

48

−1

−2.052

0

0

0

15

REACTOME_AMYLOID_FIBER_FORMATION

89

−1

−2.047

0

0

0

16

REACTOME_HDACS_DEACETYLATE_HISTONES

71

−1

−2.033

0

0

0

17

WALLACE_PROSTATE_CANCER_RACE_UP

289

−1

−2.024

0

0

0

18

REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS

42

−1

−2.02

0

0

0

19

REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA

54

−1

−2.012

0

0

0

20

REACTOME_DNA_METHYLATION

46

−1

−2.012

0

0

0